March 16 (Reuters) - Canada on Tuesday updated its guideline to recommend use of AstraZeneca (NASDAQ:AZN)'s AZN.L COVID-19 vaccine in people aged 65 years and older.
The National Advisory Committee on Immunization said it had considered recent real-world effectiveness studies to inform this change in recommendation. (https://